1. Home
  2. TNXP vs NCRA Comparison

TNXP vs NCRA Comparison

Compare TNXP & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.98

Market Cap

172.7M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$0.21

Market Cap

5.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
NCRA
Founded
2007
2002
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
172.7M
5.6M
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
TNXP
NCRA
Price
$12.98
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
407.6K
442.1K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
91.75
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
$558.11
N/A
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.85
N/A
52 Week Low
$11.60
$0.18
52 Week High
$69.65
$2.40

Technical Indicators

Market Signals
Indicator
TNXP
NCRA
Relative Strength Index (RSI) 42.46 34.93
Support Level $11.60 $0.18
Resistance Level $20.36 $0.32
Average True Range (ATR) 1.13 0.03
MACD -0.07 0.01
Stochastic Oscillator 24.96 24.44

Price Performance

Historical Comparison
TNXP
NCRA

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: